Zhong A. et al, Effectiveness of Automated Insulin Management Features of the Medtronic 640G Sensor-Augmented Insulin Pump.Diabetes Technol Ther. 2016;18(10): 657-663.
- 75% of SmartGuard predicted hypoglycaemic events did not reach the pre-set low limit
- Less glycemic variability and faster hypoglycaemia recovery when user does not intervene with suspension
- MiniMed 640G users were utilizing Automatic Insulin delivery suspension (and sensor use) for 94% of days, aprox 20% more than on MiniMed Veo and 530G